Supernus Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Abbott USD 3.05B 144M 2025-03
ANI Pharmaceuticals USD 76.53M 6.81M 2025-03
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 90.66M 7.29M 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Indivior 132M 179M 2025-03
Novo Nordisk 16.11B 480M 2025-03
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
United Therapeutics USD 170.1M 7.6M 2025-03
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Supernus Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.